ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)
ExonHit Therapeutics hopes to commercialize a microarray-based clinical test for diagnosing Alzheimer’s disease in Europe by the first quarter of next year, the company said this week.
More:
ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)
Related posts:
- Researchers Publish Data on Gene Variant Associated with Late-Onset Alzheimer’s Disease (GenomeWeb News)
- Test improves Alzheimer diagnosis (BBC News)
- Sea Squirt Helps Researchers Test New Alzheimer’s Drug (HealthDay via Yahoo! News)
- Alzheimers Disease: – New home service to launch
- Imaging Test Detects Alzheimer’s Disease That Is Likely To Progress (Medical News Today)